Stay updated with breaking news from Pipeline Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Total Revenues of $469.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $409.6 million - - GAAP Diluted EPS of $0.25, Non-GAAP Diluted EPS of $0.31 - - Conference Call and Webcast...
06.03.2023 - BOTHELL, Wash., March 06, 2023 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that ... Seite 1